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The human cytomegalovirus (HCMV) UL112–113 gene products play important roles in viral DNA replication and tran-
scriptional regulation. In this report, we characterize two novel transcripts originating from the homologous M112–113 (e1)
region of the murine cytomegalovirus (MCMV) genome. These transcripts of 2.0 and 2.4 kb represent alternatively spliced
products of the e1 gene region. Analysis of the e1 proteins demonstrates the presence of a previously unidentified 87-kDa
protein that is likely encoded by the 2.4-kb transcript. All four protein products derived from the e1 gene region are expressed
with early kinetics, are coordinately regulated, and localize predominantly to the nucleus of MCMV-infected cells. The
expression pattern and localization of the e1 proteins show significant similarity to those of the HCMV UL112–113 proteins,
signifying that MCMV e1 will serve as a useful model for assessing the role of this early gene region during viral infection.INTRODUCTION
Human cytomegalovirus (HCMV) is a ubiquitous hu-
man pathogen capable of both acute and persistent
infection (Pass, 2001). The serious medical problems
associated with HCMV infections, particularly in new-
borns and immunocompromised individuals, have pro-
vided a major impetus for understanding the molecular
biology of the virus and the regulatory mechanisms gov-
erning its replication. Infection of permissive cells with
HCMV leads to a sequential expression of viral genes
characterized by three kinetic classes: immediate-early
(IE), early, and late, (Mocarski and Courcelle, 2001). The
expression of early gene products is generally thought to
be a commitment point for viral DNA replication and the
subsequent production of progeny virus. Determining the
function of early gene products is therefore essential for
understanding the critical events controlling productive
infection.
An early gene region of particular interest is HCMV
UL112–113, whose products are directly or indirectly in-
volved in viral DNA replication (Ahn et al., 1999; Pari and
Anders, 1993; Penfold and Mocarski, 1997; Sarisky and
Hayward, 1996). The HCMV UL112–113 gene region en-
codes four nuclear phosphoproteins that arise from a set
1 To whom correspondence and reprint requests should be ad-
dressed at the Department of Microbiology and Molecular Cell Biology,199of four alternatively spliced transcripts (Fig. 1A) (Staprans
and Spector, 1988; Wright and Spector, 1989). This gene
region is regulated temporally with respect to splicing
patterns and translational control, resulting in differential
accumulation of the individual proteins during infection
(Wright and Spector, 1989). The HCMV UL112–113 pro-
teins likely function in both viral DNA replication and
regulation of HCMV gene expression (Iskendarian et al.,
1996; Pari and Anders, 1993; Sarisky and Hayward, 1996).
They bind single- and double-stranded DNA and are
localized in characteristic nuclear inclusions early after
infection (Iwayama et al., 1994). These inclusions corre-
spond to subnuclear sites of assembly of the HCMV
replication components (Ahn et al., 1999; Penfold and
Mocarski, 1997). In addition, antisense RNA to UL112–
113 transcripts suppresses viral DNA replication
(Yamamoto et al., 1998). These results suggest that
UL112–113 products have a direct role in viral DNA rep-
lication.
The HCMV UL112–113 proteins may also function as
transcriptional regulators. The UL112–113 products co-
operate with viral regulatory proteins, including the major
IE proteins, to markedly enhance activation of six HCMV
early promoters (Iskendarian et al., 1996). Significantly,
all of the viral promoters assessed in this study regulate
the expression of viral genes involved in DNA replication.
Further studies on the HCMV DNA polymerase (UL54)
promoter demonstrated that the UL112–113 gene prod-
ucts alone are sufficient to enhance activation of this© 2002 Elsevier Science (USA)
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Therefore, the HCMV UL112–113 gene products may
function directly in viral DNA replication and indirectly, by
enhancing the expression of other HCMV early genes
critical to the production of progeny virus. However, their
precise role in HCMV replication during a natural infec-
tion is still poorly understood.
HCMV UL112–113 has a positional homologue in mu-
rine cytomegalovirus (MCMV), M112–113 or e1 (Rawlin-
son et al., 1996). The MCMV e1 gene region has previ-
ously been shown to generate three antigenically related
proteins of 36, 37, and 38 kDa from a single fully spliced
2.6-kb transcript (see Fig. 1B) (Buhler et al., 1990). The
proteins are phosphorylated and localize to MCMV-in-
fected cell nuclei. A 33-kDa protein, possibly translated
from a second unspliced e1 transcript of 3.0 kb, was also
identified as a product of the e1 gene (Buhler et al., 1990).
Alignment of deduced amino acid sequences from the
MCMV e1 2.6-kb mRNA and the HCMV UL112–113 2.2-kb
mRNA demonstrates 30% identity (Buhler et al., 1990). In
three specific regions (MCMV amino acids 63–71, 84–94,
and 104–118) the identities are markedly higher at 100,
72, and 73%, respectively (Buhler et al., 1990). Our com-
parison of the MCMV e1 and HCMV UL112–113 nucleo-
tide sequences predicts the existence of two additional
FIG. 1. Comparison of the HCMV UL112–113 and MCMV M112–113 (e1) gene regions. (A) The four HCMV UL112–113 alternatively spliced transcripts
and their respective proteins are depicted (Staprans and Spector, 1986; Wright and Spector, 1989). Stop codons are represented by asterisks. (B) Map
outlining the location of the MCMV e1 gene region within the viral genome, as well as the locations of restriction sites and the positions of exons
and introns of the e1 transcripts. The two known transcripts of 3.0 and 2.6 kb (solid shaded boxes) and their proteins of 33 and 36–38 kDa, respectively,
are indicated (Buhler et al., 1990). The two predicted e1 transcripts and their corresponding protein products of 38 and 66 kDa are also shown. The
location of the e1RTF, e1RTR1, and e1RTR2 primer binding sites within the e1 gene region are depicted.
200 CIOCCO-SCHMITT ET AL.
alternatively spliced e1 transcripts and protein products
not previously reported.
The purpose of this study was to determine whether
additional MCMV e1 transcripts or proteins are gener-
ated in MCMV-infected cells and to characterize their
kinetics and localization. Our data show that two addi-
tional transcripts of 2.0 and 2.4 kb are generated from the
MCMV e1 gene region as a result of alternative splicing.
The 2.0-kb transcript is predicted to encode the 38-kDa
e1 protein that was previously believed to originate from
the 2.6-kb e1 mRNA. A newly identified e1 protein of 87
kDa is likely a posttranslationally modified product of the
2.4-kb transcript. All four e1 proteins are coordinately
regulated, are expressed with early kinetics, and localize
predominantly in the nuclei of infected cells. Therefore,
these studies have identified two unique MCMV e1 al-
ternatively spliced transcripts, as well as an additional
novel e1 protein product. The stronger similarities be-
tween the MCMV e1 and the HCMV UL112–113 gene
regions revealed by these new data suggest that MCMV
is an appropriate model for studying the role of early
genes involved in the regulation of viral gene expression
and viral DNA replication.
RESULTS
Generation of 3T3e1 cells
To assist in the analysis of products expressed exclu-
sively from the MCMV e1 gene region, a NIH3T3 cell line
stably expressing e1 under the control of the cognate
promoter (3T3e1) was generated. Clones that were G418
resistant and contained an e1 insertion of the correct
size as determined by Southern blot analysis (data not
shown) were chosen for subsequent studies. To assess
expression of e1 mRNA, the 3T3e1 cells were transiently
transfected with plasmid pIE111, expressing the MCMV
ie1 and ie3 genes, which are necessary for activation of
e1 gene expression (Koszinowski et al., 1986). At 48 h
after transfection total cell RNA was isolated and sub-
jected to RT-PCR, using primers e1RTF and e1RTR that
target the region across intron 1 (Fig. 1B). Use of these
e1 primers in RT-PCR was predicted to generate two
products: one 371-bp unspliced product and one 278-bp
spliced product.
Our results revealed the presence of two products of
approximately 370 and 280 bp that were amplified from
the 3T3e1 cells (Fig. 2A, lane 8). Identical products were
also amplified from MCMV-infected NIH3T3 cells (Fig.
2A, lane 6). Therefore, 3T3e1 cells transcribe e1 mRNA
indistinguishable from that detected in infected cells.
Importantly, no product was detected in reactions that
did not undergo treatment with reverse transcriptase,
demonstrating a lack of DNA contamination (Fig. 2A, lane
7). A third faint product of approximately 400 bp was
observed in samples from MCMV-infected NIH3T3 cells
and 3T3e1 cells (Fig. 2A, lanes 6 and 8), but not from the
pcDNA3e1 plasmid (Fig. 2A, lane 4). This band is likely a
nonspecific product, as it was also observed in samples
amplified with -actin primers (Fig. 2A, lane 9). Additional
studies by immunofluorescence using an e1 monoclonal
antibody (Buhler et al., 1990) confirmed that the 3T3e1
cells expressed e1-related proteins that localized to the
nuclei of infected cells (data not shown), similar to the
localization of e1 during MCMV infection (Buhler et al.,
1990). Overall, these studies suggested that the 3T3e1
cells will be useful for further characterization of the e1
gene region.
Sequence analysis of the e1 gene region
The MCMV e1 gene region was previously reported to
synthesize two mRNAs: a fully spliced transcript of 2.6 kb
and an unspliced transcript of 3.0 kb (Buhler et al., 1990).
In contrast, the HCMV counterpart UL112–113 gives rise
FIG. 2. RT-PCR analysis of MCMV e1 transcripts. (A) RT-PCR was
performed on RNA samples as described under Materials and Meth-
ods; the products were resolved on a 2% agarose gel and stained with
ethidium bromide. Lane 1, 1 kb DNA ladder; lane 2, no template control;
lane 3, pcDNA3/e1 plasmid with no primers; lane 4, pcDNA3/e1 plas-
mid amplified with e1 primers; lane 5, cDNA from mock-infected cells
amplified with e1 primers; lane 6, cDNA from MCMV-infected cells
amplified with e1 primers; lane 7, RNA samples from 3T3e1 cells
transfected with the pIE111 to activate e1 gene expression and ampli-
fied with e1 primers in the absence of the reverse transcriptase reac-
tion; lane 8, cDNA from 3T3e1 cells transfected with pIE111 and am-
plified with e1 primers; lane 9, cDNA from 3T3e1 cells transfected with
pIE111 and amplified with -actin primers. (B) RT-PCR was performed
on RNA samples as described under Materials and Methods; the
products were resolved on a 1% agarose gel and stained with Gel Star
nucleic acid stain. Lanes 1 and 9, 1 kb ladder; lane 2, pcDNA.3/e1
plasmid amplified with the e1 primers; lane 3, cDNA from mock-
infected NIH3T3 cells; lane 4, RNA from infected NIH3T3 cells amplified
in the absence of the reverse transcriptase reaction; lane 5, cDNA from
infected NIH3T3 cells; lane 6, cDNA from mock-transfected cells; lane
7, RNA from transfected 3T3e1 cells amplified with e1 primers in the
absence of the reverse transcriptase reaction; lane 8, cDNA from
transfected 3T3e1 cells.
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to four distinct transcripts as a result of alternate splicing
(Staprans and Spector, 1986). We therefore performed a
sequence alignment to compare the HCMV and MCMV
gene regions and to search for alternate donor and
acceptor splice sites (PCGene). This analysis revealed
two potential additional MCMV transcripts of 2.0 and 2.4
kb (Fig. 1B). The 2.0-kb transcript could be generated
from the use of an alternative acceptor site approxi-
mately 1660 bp downstream of the cap site. The 2.4-kb
transcript is predicted to arise as a result of a single
splice by which the first intron is removed and the sec-
ond intron is retained. These two MCMV e1 transcripts
would encode proteins with the calculated molecular
weights of 38 and 66 kDa, respectively. Alignment of the
deduced amino acid sequences of the four e1 gene
products with the corresponding HCMV UL112–113 pro-
teins demonstrated an average identity of approximately
29%. However, Blast analysis indicated that the 36-kDa,
predicted 38-kDa, and predicted 66-kDa proteins share a
region (MCMV e1 amino acids 279–285) with 85% iden-
tity and the 66-kDa protein has two regions (MCMV e1
amino acids 456–466 and 575–581) with 81% and 85%
identities, in addition to the three conserved domains
previously described (Buhler et al., 1990). Based on this
analysis, we speculated that the MCMV M112–113 e1
gene expressed two previously undescribed RNA spe-
cies and at least one other additional protein.
e1 transcript analysis by RT-PCR
In order to determine whether the predicted 2.0- and
2.4-kb e1 splice products were expressed in MCMV-
infected cells or 3T3e1 cells, transcripts originating from
this region were identified by RT-PCR. This methodology
was chosen as previous Northern analysis (Buhler et al.,
1990) did not reveal distinct transcripts of this size, sug-
gesting that these mRNAs may be of lower abundance.
NIH3T3 cells were infected with 5 PFU/cell MCMV and
total cell RNA was isolated at an early time in infection
(approximately 3.5 hpi). In addition, 3T3e1 cells were
either mock or transiently transfected with pIE111, and
total cell RNA was isolated at 48 h after transfection. We
then performed RT-PCR using the e1RTF and e1RTR2
primers to distinguish individual transcripts based on
whether intron 1 and/or 2 was spliced (Fig. 1B). Based on
our sequence analysis, four products were expected to
be amplified by this e1 primer pair: one unspliced prod-
uct, two fully spliced products, and a partially spliced
product with the calculated sizes of 1472, 1053, 901, and
1379 bp, respectively (Fig. 1B).
Our results demonstrated that the four predicted RT-
PCR products (1.5, 1.4, 1.1, and 0.9 kb) are detected in
NIH3T3 cells infected with MCMV, as well as in 3T3e1
cells (Fig. 2B, lanes 5 and 8). Moreover, the two larger e1
transcripts in MCMV-infected cells were consistently
less abundant than their fully spliced counterparts at 3.5
hpi (Fig. 2B, lane 5). In comparison, all four e1 transcripts
in the 3T3e1 cells were equally abundant (Fig. 2B, lane
8). Semiquantitative RT-PCR demonstrated that the rela-
tive amounts of the four RT-PCR products peaked at early
times in infection (4 hpi) and then declined only to rise
again at late times after 12 hpi (data not shown). This
biphasic appearance of the e1 transcripts was previously
observed by Buhler et al. (1990). Thus, while the corre-
sponding levels of the individual transcripts are likely
subject to posttranscriptional regulation, the overall ki-
netics of the e1 transcripts appeared to be coordinately
regulated.
Analysis of e1 proteins in infected and transfected
cells
To determine if these novel e1 transcripts generate
protein products, polyclonal antisera were generated
against a recombinant e1 fusion protein containing the
predicted common amino-terminal region. Results of im-
munoprecipitation experiments using these antisera re-
vealed the presence of at least four e1 products of 33, 36,
38, and 87 kDa in MCMV-infected cells (Fig. 3A). Two
other proteins of 40 and 110 kDa were also detected.
Since the HCMV UL112–113 gene products are phospho-
proteins, the 40-kDa protein that appears as a doublet
with the 38-kDa protein is likely an e1 protein modified by
phosphorylation. The origin of the 110-kDa protein was
not identified. However, this protein was not detected by
subsequent Western blot analyses and thus is likely a
protein bound nonspecifically by the polyclonal anti-
serum. Steady-state levels of the e1 proteins were then
assessed by Western blot analysis (Fig. 3B). As de-
scribed previously (Buhler et al., 1990), the e1 monoclo-
nal antibody detected only the 36- and 38-kDa proteins
(Fig. 3B, lane 4). In contrast, four proteins (33, 36, 38, and
87 kDa) were detected in MCMV-infected cell lysates by
the e1 polyclonal antiserum (Fig. 3B, lane 6), strongly
suggesting that these four proteins are products of the
e1 gene. Again, the 33- and 38-kDa proteins appeared as
doublets that may be the result of posttranslational mod-
ification.
To confirm that all four proteins in infected cell lysates
were e1-specific, Western blot analyses were performed
using lysates from 3T3e1 cells or NIH3T3 cells tran-
siently transfected with the e1-expressing construct,
pcDNA3e1 (Fig. 3C). All four e1-specific products were
detected in NIH3T3 cells transiently transfected with the
MCMV e1 gene and its activator, MCMV ie1/3 (Fig. 3C,
lane 5), but not in mock-transfected NIH3T3 cells or
NIH3T3 cells transfected with the ie1/3 gene region
alone (Fig. 3C, lanes 3 and 4). Surprisingly, the 3T3e1
cells expressed all four e1 products in the absence of
MCMV ie1/3 (Fig. 3C, lanes 1 and 2), suggesting that
expression of e1 in these cells may be constitutive.
However, the relative abundance of the four e1 proteins
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was greater in the 3T3e1 cells transfected with the
MCMV ie1 and 3 gene region compared to the mock-
transfected 3T3e1 cells. The 33- and the 38-kDa proteins
appeared as doublets in NIH3T3 cells transfected with
e1 and pIE111 (Fig. 3C, lane 5), but not in the 3T3e1 cells
(Fig. 3C, lanes 1 and 2). This difference may be related to
the reduced level of e1 protein expression in these cells
compared to both infected and transfected NIH3T3 cells.
Overall, the results of both immunoprecipitation and
Western blot analysis consistently demonstrated the
presence of four proteins of 33, 36, 38, and 87 kDa that
are e1-specific.
The MCMV e1 33- and 36- to 38-kDa proteins were
previously classified as early proteins (Buhler et al.,
1990). To identify the kinetic class of the newly identified
e1 gene products, infected cell lysates harvested at
various time points over a period of 24 hpi were analyzed
by Western blot using the e1 polyclonal antiserum (Fig.
4). All four MCMV e1 proteins were present at early times
(2 hpi) and their levels steadily increased during infec-
tion. At 2 hpi, the 33- and 87-kDa proteins were less
abundant than the 36- and 38-kDa proteins (Fig. 4). This
result was expected because the levels of the unspliced
and partially spliced transcripts generating the 33- and
87-kDa proteins, respectively, were less abundant than
the fully spliced transcripts generating the 36- and 38-
kDa proteins (Fig. 2B). Therefore, the kinetics of expres-
sion for both the e1 transcripts and their corresponding
proteins were temporally coregulated in agreement with
previous observations (Buhler et al., 1990).
To confirm the kinetic class of the novel e1 proteins,
cells were treated with the inhibitor phosphoonoformic
acid (PFA) during viral infection, to restrict viral replica-
tion to the early phase, and assessed by Western blot
analysis (Fig. 4). These studies demonstrated that PFA
did not inhibit the expression of the four e1 proteins,
indicating that their synthesis does not require viral DNA
replication and thus they are not late proteins. Further
experiments demonstrated that none of the four e1 pro-
teins were detected after treatment of MCMV-infected
cells with anisomycin and actinomycin D to enrich for the
expression of IE proteins (data not shown), suggesting
that they are not of the immediate-early kinetic class. We
FIG. 3. Analysis of e1 protein products. (A) Mock- and MCMV-infected cells were 35S labeled and lysates subjected to immunoprecipitation as
described under Materials and Methods using e1 polyclonal antisera. Lane 1, mock-infected lysate; lane 2, MCMV-infected lysate. (B) Mock (odd
lanes) and infected cell lysates (even lanes) were subjected to Western blot analysis using the following antibodies: lanes 1 and 2, preimmune sera;
lanes 3 and 4, e1 monoclonal antibody 20/234/28; lanes 4 and 5, el polyclonal antiserum EVMS 55B. (C) Parental NIH3T3 cells and 3T3e1 cells were
either mock transfected (lanes 1 and 3) or transiently transfected with pIE111 plasmid (lanes 2 and 4). Parental NIH3T3 cells were also transfected
with both pIE111 and pcDNA3e1 (lane 5). Cell extracts were harvested 48 h after transfection and were analyzed by Western blot using e1 polyclonal
antisera EVMS 55B.
FIG. 4. Determination of kinetic class of e1-related proteins. NIH3T3
cells were either mock infected (M) or infected with MCMV and har-
vested at the indicated hours postinfection (hpi). Alternatively, cells
were infected in the absence () or presence () of PFA and harvested
at 24 hpi. Cell lysates were then analyzed by Western blot using e1
polyclonal antisera, EVMS 55B.
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concluded from these data that all four e1 proteins are
“true” early proteins.
Localization of e1 proteins
HCMV UL112–113 localize in the nucleus of infected
cells, likely related to their function in transactivation and
viral DNA replication. If the MCMV e1 proteins were
functional homologues of the HCMV UL112–113 gene
products, it would be expected that the MCMV e1 pro-
teins would have a similar compartmentalization. Indeed,
previous studies demonstrated that the 36- to 38-kDa
MCMV e1 proteins do exhibit nuclear localization (Buhler
et al., 1990). To identify the subcellular localization of all
four e1 gene products, nuclear and cytoplasmic fractions
of MCMV-infected cells were analyzed by Western blot
using e1 polyclonal antisera (Fig. 5A, lanes 1–8). All four
e1 proteins appeared predominantly in the nuclear frac-
tion (Fig. 5A, lanes 3 and 7), although lesser amounts of
the 36- to 38-kDa proteins were also present in the
cytoplasm (Fig. 5A, lanes 4 and 8). Assessment of the
same fractions for nuclear (SP1; Fig. 5A, lanes 15–20)
and cytoplasmic proteins (protein tyrosine phosphatase–
PEST; Fig. 5A, lanes 9–14) demonstrated clean separa-
tion of the nuclear and cytoplasmic compartments.
Results of the cell fractionation were confirmed by
immunofluorescence using the e1 polyclonal antibody
followed by confocal microscopy. These studies demon-
strated an intense fluorescence in the nuclei of infected
cells (Fig. 5B, b–d), in contrast to mock-infected cells
(data not shown) and cells treated with preimmune se-
rum (Fig. 5B, a). Interestingly, staining of the nuclei in
infected cells appeared to vary. In some cases, staining
was punctate in appearance (Fig. 5B, c) or was confined
to specific locations within the nucleus (Fig. 5B, d). In
other cases, it was much less defined and appeared to
cover a larger area within the nucleus (Fig. 5B, d). Over-
all, the results of both studies suggest that all four e1
proteins are predominantly located in the nuclei of in-
fected cells.
DISCUSSION
The UL112–113 gene region of HCMV encodes four
proteins (Wright and Spector, 1989) that function in viral
DNA replication by assisting in the activation of the viral
replication genes (Iskendarian et al., 1996; Kerry et al.,
1996). In addition, the UL112–113 gene products may
have a more direct role in viral DNA replication (Ahn et
al., 1999; Penfold and Mocarski, 1997; Sarisky and Hay-
ward, 1996; Yamamoto et al., 1998). However, the analy-
sis of this complex gene region has been hampered by
the difficulty of generating complementing cell lines for
this virus. For this reason, we have begun to characterize
the homologous e1 gene region in MCMV. In contrast to
the HCMV UL112–113 region, the e1 gene of MCMV was
previously reported to encode only two transcripts, gen-
erating three related proteins (Buhler et al., 1990). In this
study, we describe two additional transcripts that arise
from MCMV e1 and a novel protein product. The two
additional transcripts that we describe are both products
of alternate splicing events. The 2.4-kb transcript shares
similarity with the 2.5-kb transcript of the HCMV coun-
terpart, in that it arises as a result of a single splice by
which intron 2 is retained (Fig. 1). This transcript would
encode a predicted 66-kDa protein that shares a com-
mon amino terminus with other e1 proteins, but varies in
the carboxy terminus. Using a polyclonal antiserum rec-
ognizing the common amino-terminal region, we identi-
fied a unique 87-kDa protein that originates from the e1
gene region. This protein, which is not recognized by the
monoclonal antibody used in previous studies (Buhler et
al., 1990), is homologous to the 84-kDa HCMV UL112–113
product.
The second novel transcript of 2.0 kb is analogous to
the HCMV 2.1-kb transcript in that it is fully spliced but
utilizes an alternative acceptor site downstream of the
splice junction that was previously characterized (Buhler
et al., 1990) (Fig. 1B). Based on the predicted protein size,
and by analogy with UL112–113, it is likely that this
transcript is responsible for the 38-kDa protein that was
originally thought to derive from posttranslational modi-
fications of the 36-kDa protein product (Buhler et al.,
1990). Our studies nonetheless provide evidence that the
e1 protein products do undergo posttranslational modi-
fications. For example, both the 33- and the 38-kDa
proteins typically appear as doublets in MCMV-infected
cells. This is in agreement with the studies on the HCMV
UL112–113 gene products demonstrating that these pro-
teins are phosphorylated (Wright et al., 1988). Interest-
ingly, these doublets were not detected in cells that were
stably transfected with the e1 gene region. The appear-
ance of the posttranslationally modified e1 proteins cor-
related best with high levels of the 87-kDa protein prod-
uct, suggesting that there may be some level of interac-
tion, either directly or indirectly, among the e1 proteins.
Alternatively, these data suggest that a viral kinase or
additional viral proteins may be involved in the phosphor-
ylation of the e1 proteins. These possibilities will be
examined in further studies.
Results of e1 protein localization studies confirmed the
previous report that products of the MCMV e1 gene
region localize primarily in the nucleus (Buhler et al.,
1990). Interestingly, in MCMV-infected cells we observed
three distinct patterns of e1 protein localization. In some
cells, a diffuse nuclear staining was observed. In other
cells, the staining had a punctate appearance or was
confined to specific locations within the nucleus. This
finding is consistent with studies on the HCMV UL112–
113 proteins that demonstrate accumulation adjacent to
PML oncogenic domains (Ahn et al., 1999; Penfold and
Mocarski, 1997). The subnuclear localization of UL112–
113 proteins correlates with sites of viral DNA replication
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compartments. Further, it has been suggested that
UL112–113 may play a role in the recruitment of the DNA
replication machinery (Ahn et al., 1999). The observation
that the e1 proteins share a similar distinct subnuclear
localization lends additional support to the notion that
these proteins share a similar function.
Previous studies demonstrated three regions of amino
acid homology between the HCMV UL112–113 proteins
and the known products of the e1 gene region (Buhler et
al., 1990). The novel coding regions identified in this
study also share several distinct homology domains with
their HCMV counterparts. For example, sequences from
FIG. 5. Localization of e1 proteins in MCMV-infected cells. (A) NIH3T3 cells were either mock infected or infected with MCMV and harvested at
4 or 24 h postinfection. Lysates were fractionated into nuclear (odd lanes) and cytoplasmic (even lanes) compartments as described under Materials
and Methods. Cell fractions were analyzed by Western blot using e1 polyclonal antisera (EVMS 55B), PTP–PEST polyclonal antisera, or SP1 antibody.
Arrows indicate the e1 proteins in lanes 1–8, the PTP-PEST protein in lanes 9–14, and the SP1 proteins in lanes 15–20. (B) NIH3T3 cells were infected
with MCMV and subjected to indirect immunofluorescence assay as described under Materials and Methods using e1 polyclonal antibody, EVMS
55B (b–d) or preimmune sera (a). Samples were examined by confocal microscopy. Multiple Z-series images [original magnification of either 40 (a
and b) or 60 (c and d)] were scanned at 1-m intervals and then projected onto a single plane. Arrows demonstrate varying distributions of
fluorescence within the nuclei.
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amino acid 577 to 591 of the 87-kDa protein (RGRRGP-
DLTEDGLEI) share 73% identity with a corresponding
carboxy-terminal region of the HCMV 84-kDa protein
(RRRGPSFLEDGLEI). It is likely that amino acid homolo-
gies between the two proteins reflect shared functional
domains. Indeed, our preliminary studies demonstrate
that a region required for transcriptional activation by the
UL112–113 proteins maps to the homologous domain
from amino acids 104–118 of the MCMV e1 proteins.
These regions of sequence homology will therefore be
targeted in future studies to characterize the function of
these proteins during MCMV infection. In summary,
these studies establish a high degree of conservation
between the products of the 112–113 gene region in both
viruses and strongly suggest that MCMV will provide an
appropriate model system to further analyze the function
of this important viral gene.
MATERIALS AND METHODS
Plasmid constructs
A HindIII-F MCMV genomic clone (nucleotides
150,754–173,619 of the MCMV genome) was used to
generate all subsequent constructs containing the
MCMV e1 gene region (Cavanaugh et al., 1996). All
subcloning was conducted by standard methods (Mania-
tis et al., 1987). Restriction endonucleases were pur-
chased from either New England Biolabs (Beverly, MA)
or Gibco BRL (Grand Island, NY) and digestions were
performed according to manufacturer’s specifications.
For transient and stable expression of the e1 gene region
in fibroblasts, a plasmid containing the e1 gene and
cognate promoter region (pcDNA3e1) was generated.
The HindIII-F genomic clone was digested with XbaI and
NdeI (bp 162,831–166,517 within the MCMV genome) and
this fragment was inserted into the corresponding sites
in the pcDNA3 plasmid. This cloning resulted in the
removal of 379 bp from the 3 end of the HCMV major
immediate early promoter present in pcDNA3.
A plasmid was also constructed to express the e1
gene with a histidine tag in bacteria for purification as an
immunogen to generate e1-specific polyclonal antibod-
ies. The e1 gene region containing coding sequences
from amino acid 1 to 266 was cloned in frame into
pTrcHisA (Invitrogen, Carlsbad, CA) to generate pTrcHis/
e1.
The pIE111 construct, containing the MCMV ie 1 and 3
gene regions under control of the MCMV major immedi-
ate early promoter, was kindly provided by Martin Mes-
serle (Max Von Pettenkofer-Institut, Munich, Germany)
(Koszinowski et al., 1986).
Virus and cells
The parental wild-type MCMV Smith strain (ATCC VR-
194) was propagated and titered on NIH3T3 fibroblasts
as previously described (Campbell et al., 1989). Murine
NIH3T3 fibroblasts from American Type Culture Collec-
tion (ATCC CRL-1658; Rockville, MD) were propagated in
Dulbecco’s modified essential medium (Mediatech,
Herndon, VA) supplemented with 10% heat-inactivated
bovine calf serum (Hyclone Laboratories, Logan, UT) and
1% L-glutamine (Gibco BRL). Infections in the presence of
viral inhibitors were performed as previously described
(Campbell et al., 1992; Hanson et al., 1999; Stinski et al.,
1983). Briefly, anisomycin (100 M) was added to NIH3T3
cells 1 h prior to infection and then replaced with 10
g/ml actinomycin D at 3 hpi. Phosphoonoformic acid
(300 g/ml) was added at the time of infection.
Generation of 3T3e1 cells
Parental NIH3T3 cells were transfected with
pcDNA3e1 using Lipofectamine (Gibco BRL) according
to the manufacturer’s protocol. At 72 h after transfection,
cells were selected for neomycin resistance by passage
into complete media containing 400 g/ml Geneticin
selective antibiotic (G418; Gibco BRL). G418-resistant
colonies were isolated and assessed for e1 insertion by
Southern blot analysis as previously described (Chau et
al., 1999; Kerry et al., 1996).
RT-PCR
Total cell RNA was isolated using the RNeasy Kit
(Qiagen) according to the manufacturer’s protocol. First-
strand cDNA synthesis was performed with 1 g total
RNA using oligo(dT)20 primers (ThermoScript RT-PCR
System; Gibco) following DNase treatment to eliminate
genomic DNA contamination. The cDNA was then
treated with RNase H and 1 l of a 1:10 dilution used for
PCR with primers designed to amplify -actin (kindly
provided by George L. Wright, Jr., Eastern Virginia Med-
ical School, Norfolk, VA) or the e1 gene region (sense,
E1RTF 5-TGACGACCGACGTAAGAGAT-3, and anti-
sense, E1RTR 5-CGTCTGCATTACCATCGACA-3 or
E1RTR2 5-CTTGCTTGCGTGCTTACAGA-3). PCR was
performed according to the manufacturer’s protocol for
the FailSafe PCR System (Epicentre Technologies, Mad-
ison, WI) for 25 cycles of 1 min at 95°C, 1 min at 53°C,
and 2 min at 72°C. The final cycle was followed by a
7-min polymerization at 72°C. PCR products were visu-
alized on a 1% agarose gel stained with Gel Star nucleic
acid gel stain (Bio-Whittaker Molecular Applications,
Rockland, ME) unless otherwise stated. Band intensities
were determined using the Kodak Electrophoresis Doc-
umentation and Analysis System 120 and normalized
according to the corresponding -actin band.
Antibodies
Monoclonal antibodies to e1 proteins (20/234/28) and
to the m123 protein pp89 (6/20/1 and 6/58/1) were kindly
provided by Ulrich Koszinowski (Max Von Pettenkofer-
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Institut, Munich, Germany) (Buhler et al., 1990; Redde-
hase et al., 1986). Mouse IgG was purchased from Cap-
pel (Durham, NC). The protein tyrosine phosphatase–
PEST polyclonal antiserum was kindly provided by
Michael L. Tremblay (McGill University, Montreal, Que-
bec, Canada) (Charest et al., 1995). The SP1 (PEP2)
polyclonal antibody was purchased from Santa Cruz Bio-
technology (Santa Cruz, CA).
To generate polyclonal antibodies to the e1 protein,
the Xpress System (Invitrogen) was used to purify the
His-tagged e1 recombinant protein according to manu-
facturer’s protocol. Induction and purification of His-
tagged e1 protein was verified by Western blot analysis
using e1 monoclonal antibody (20/234/28) and anti-His
antibody (Qiagen, Inc., Valencia, CA). The partially puri-
fied His-tagged e1 recombinant protein was then used to
immunize two rabbits to generate polyclonal e1 antisera
(Cocalico Biologicals, Inc., Reamstown, PA). Antiserum
from one rabbit, EVMS55B, was used exclusively in this
study.
Western blot
Protein samples were prepared by lysis in 50 mM Tris
buffer, pH 7.5, containing 1% SDS. Proteins were resolved
by SDS–PAGE on 12.5% acrylamide, unless otherwise
stated, and then transferred to Nitro-Pure nitrocellulose
membrane (Osmonics, Inc., Westborough, MA). Mem-
branes were treated at 4°C overnight in blocking buffer
[TBS-T (10 mM Tris, 150 mM NaCl, and 0.5% Tween)
containing 5% nonfat dry milk] before being incubated
with antibody diluted in blocking buffer for 1 h at room
temperature. Membranes were then washed three times
with TBS-T before being incubated with a 1:10,000 dilu-
tion of either goat anti-rabbit or goat anti-mouse IgG
conjugated with horseradish peroxidase (Sigma, St.
Louis, MO) in blocking buffer. Detection was performed
by enhanced chemiluminescence according to the man-
ufacturer’s protocol for ECL Western blotting detection
reagents (Amersham, Piscataway, NJ).
Immunoprecipitation
NIH3T3 cells were infected with 1 PFU/cell MCMV and
then 35S labeled for 4 h at approximately 20 hpi. Immu-
noprecipitations were performed using e1 polyclonal an-
tisera as previously described (Campbell and Slater,
1994; Kierstead and Tevethia, 1993) except that cells
were radiolabeled with [35S]methionine/cysteine mix and
the lysis buffer contained 0.5% deoxycholic acid. In all
cases, precipitations were performed with equal vol-
umes of cell lysates from equal cell numbers.
Cell fractionation
Nuclear and cytoplasmic compartments of either
mock-infected NIH3T3 cells or NIH3T3 cells infected
with 2 PFU/cell WT MCMV were obtained at 4 and 24 hpi
using the NE-PER Nuclear and Cytoplasmic Extraction
Reagents (Pierce, Rockford, IL) according to the manu-
facturer’s protocol. Volumes of lysate from cytoplasmic
and nuclear fractions representing equivalent numbers
of infected cells were electrophoresed on 12.5% poly-
acrylamide gels and subjected to Western blot analysis.
Indirect immunofluorescence assay and confocal
microscopy
Approximately 1  106 3T3e1 cells were seeded onto
100-mm dishes 24 h prior to transfection with pIE111. At
24 h posttransfection, 3T3e1 cells (4  104 cells/well)
were seeded onto glass chamber slides. Alternatively,
NIH3T3 cells (1  105cells/well) were seeded onto
chamber slides and then mock infected or infected with
WT MCMV (5 PFU/cell). After 24 h, slides were fixed with
acetone for 10 min at 20°C. Slides were rehydrated
with phosphate-buffered saline containing 0.1% bovine
serum albumin (diluent) for 5 min at room temperature.
Slides were then incubated for 45 min at 37°C with one
of the following: (a) diluent, (b) 1:100 dilution of mouse
IgG, (c) 1:100 dilution of pp89 monoclonal antibody (6/
20/1), (d) undiluted e1 monoclonal antibody (20/234/28),
(e) 1:100 dilution of polyclonal e1 antisera, or (f) 1:100
dilution of preimmune sera from corresponding rabbit.
Slides were then washed three times with diluent at
room temperature and subsequently incubated at 37°C
for 30 min with either a 1:20 dilution of FITC-conjugated
goat anti-mouse antibody or a 1:100 dilution of FITC-
conjugated goat anti-rabbit antibody (Sigma, St. Louis,
MO). Slides were washed twice in diluent and once in
sterile distilled water before being mounted (90% glyc-
erol, 10% 1 M Tris, pH 9.0, 6.25 g/L n-propyl gallate) for
examination by fluorescence microscopy with an Olym-
pus biological microscope (Model BHTU Olympus Corp.,
Cherry Hill, NJ) equipped for epifluorescence (60 mag-
nification). Pictures were taken using an Olympus
C35AD-4 camera. For confocal microscopy, digital im-
ages were made using an Olympus Fluoview 100 confo-
cal laser scanning microscope. Multiple Z-series images
were scanned (magnification of either 40 or 60) at
1-m intervals and then projected onto a single plane.
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